SlideShare une entreprise Scribd logo
1  sur  17
GUIDED BY:           PREPARED BY:
MR PRAVIN MESARIYA   M.Pharm (Q.A)
                     Sem-1
   EVALUATION OF ANALGESIC AGENTS:
   THERMAL STIMULUS
   Hot-plate test
   Mice on hot plate at 55°c.
   cut off time 30 sec
   PHYSICAL STIMULUS
   Haffner’s tail clip method
   A metal artery clip was applied to the root of
    the mouse’s tail for 30 sec.
   Writhing test
   the mice were given an intraperitoneal (i.p.)
    injection of 0.6% v/v acetic acid in a volume
    of 10ml/kg to induce the characteristic
    writhings.
Carrageenan-Induced Rat Paw Edema:
Animals of group I received normal saline (3
 ml/kg b.w. intraperitoneal, i.p) and served as
 saline control.
The .groups II and III received methanol
 extract of . Clerodendron infortunatum (250
 and 500 mg/kg b.w., i.p, . respectively) and
 group IV received reference drug .
 phenylbutazone (100 mg/kg b. w., i.p)..
   EHRLICH ASCITES CARCINOMA(EAC)
   weekly intraperitoneal inoculation of 106 cells
    per mouse.
   Substances under investigation are
    administered either orally or
    intraperitoneally.
   The viability of the cells are judged by the
    trypan blue test
   viable tumour cell count is done using
    haemocytometer.
   is induced in Balb-C mice by subcutaneous
    injection of 3-methylcholanthrene(3-MC).
 defn

 The capability of producing fetal malformation.
 A given teratogen may be organ specific. It may be
  species specific. It can be dose specific.

 teratogens
 halidomide
  Accutane

 Diethylstilbestrol(DES)
  Alcohol

 OBSERVATION PARAMETERS
 Multigenerational studies
  Single generational studies
  Segment I:Evaluation of Fertility and Reproductive Performance
  Segment II: Assessment of Developmental Toxicity
  Segment II: Postnatal Evaluation

 Tests under ICH:
 Fertility Assessment
  Postnatal Evaluation and Pregnancy State Susceptibility
  Assessment of Developmental Toxicity
 diagnosis
   · colon & Rectal Cancer: Home Testing
   Home Colorectal Cancer Tests
   Home Fecal Occult Bleeding Tests
   · Pregnancy -- Related Home Testing:

   Home Pregnancy Tests
   Mutation
   A change in the DNA molecule
   Process which produces changes in the DNA that
    may be inherited.
   MECHANISM
   1. By the change in the structure of DNA which is
    responsible in inaccurate application of genome.
   2. Prevent cell proliferation that fixes the DNA
    damage.
   3. DNA repair removal of large segement of
    DNA.
   Chemical (different compounds)
    ◦   Alkylating agents
    ◦   Aromatic hydrocarbons (e.g. benzo(a)pyrene)
    ◦   Intercalating agents (e.g. fluorescent dyes)
    ◦   Artificial derivatives of DNA bases
   Physical (ionizing radiation, UV-radiation)
   Biological (viruses, transposable elements)
   Induction of in vitro mammalian cells
    resistant to certain chemical compound
    ◦ (e.g. 8-azaguanine, 6-thioguanin, ouabain)
   SOS/umu test – measurement of DNA repair
    in bacteria
    ◦ The bacteria is transformed by plasmide with
      mutator (repair) genes umuC and umuD fused
      with the gene for galactosidase. If the DNA is
      damaged by mutagen both umu mutator genes
      and gal gene are transcribed and galactosidase
      turns a specific substrate into a color product.

   Test system – auxotrophic strain of
    Salmonella typhimurium – survives only in
    medium with histidine (dies in normal
    medium without histidine)
   After treatment with mutagen some
    auxotrophic cells are turned into normal ones
    that synthesize histidine and survive in a
    normal medium.
   These cells are called revertants (due to
    reverse mutation).
Mutagen




                His–       Reverse mutation    His+
              bacteria                        bacteria




  Medium                 Dies in a            Normal
 containing               normal              medium
  histidine              medium
0   Negative
     control
                   SPONTANEOUS
                    REVERTANTS




     A dish with   GENOTOXICITY
          a         CONFIRMED
     compound
    to be tested

    Positive        IS USED FOR
                    CONTROL OF
    control           THE TEST
Number of revertant
             colonies




                               Dose of 1-nitropyrene (micrograms per dish)


   The graph describes results of the Ames test of
    various 1-nitropyrene doses.
   Describe the relationship between the dose and
    number of revertant colonies. Is it possible to
    confirm the mutagenic activity?
   Why we test the compound in various
    concentrations?
   ijppsjournal.com/Vol1Issue2/171.pdf

   healthy-synergies.com/Documents/2-2-33-
    36.pdf

   GHOSH M.N. Fundamentals of experimentaL
    pharmacology, Fourth Edition 2008. Page
    no.162-173.

Contenu connexe

Tendances (20)

Radio Immune Eassay
Radio Immune EassayRadio Immune Eassay
Radio Immune Eassay
 
Ria
RiaRia
Ria
 
Radioimmunoassay (RIA)
Radioimmunoassay (RIA)Radioimmunoassay (RIA)
Radioimmunoassay (RIA)
 
Radioimmunoassay
RadioimmunoassayRadioimmunoassay
Radioimmunoassay
 
Radio immuno assay
Radio immuno assayRadio immuno assay
Radio immuno assay
 
Week 9 radioimmunoassay
Week 9 radioimmunoassayWeek 9 radioimmunoassay
Week 9 radioimmunoassay
 
Radioimmunoassay
RadioimmunoassayRadioimmunoassay
Radioimmunoassay
 
Radio immunoassay (RIA)
Radio immunoassay (RIA)Radio immunoassay (RIA)
Radio immunoassay (RIA)
 
Radioimmunoassay (modified copy)
Radioimmunoassay (modified copy)Radioimmunoassay (modified copy)
Radioimmunoassay (modified copy)
 
Radio Immuno Assay
Radio Immuno AssayRadio Immuno Assay
Radio Immuno Assay
 
RADIO IMMUNO ASSAY
RADIO IMMUNO ASSAYRADIO IMMUNO ASSAY
RADIO IMMUNO ASSAY
 
Radioimmunoassay by Siddhartha Das
Radioimmunoassay by Siddhartha DasRadioimmunoassay by Siddhartha Das
Radioimmunoassay by Siddhartha Das
 
Application of Radioimmunoassay
Application of RadioimmunoassayApplication of Radioimmunoassay
Application of Radioimmunoassay
 
Immunological assays(1)
Immunological assays(1)Immunological assays(1)
Immunological assays(1)
 
RIA
RIARIA
RIA
 
Elisa & ria
Elisa & riaElisa & ria
Elisa & ria
 
Radioimmunoassay
RadioimmunoassayRadioimmunoassay
Radioimmunoassay
 
Molecular Biology
Molecular BiologyMolecular Biology
Molecular Biology
 
Radio Immunoassay Notes
Radio Immunoassay NotesRadio Immunoassay Notes
Radio Immunoassay Notes
 
Radioimmunoassay (ria)
Radioimmunoassay (ria)Radioimmunoassay (ria)
Radioimmunoassay (ria)
 

En vedette

23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms23117 copy of oral solid dosage forms
23117 copy of oral solid dosage formsPatel Parth
 
Qc lab 112070804001
Qc lab 112070804001Qc lab 112070804001
Qc lab 112070804001Patel Parth
 
Microbial limit test 112070804013
Microbial limit test  112070804013Microbial limit test  112070804013
Microbial limit test 112070804013Patel Parth
 
Bioassay 112070804012
Bioassay 112070804012Bioassay 112070804012
Bioassay 112070804012Patel Parth
 
HPTLC : SEPERATION TECHNIQUE
HPTLC : SEPERATION TECHNIQUEHPTLC : SEPERATION TECHNIQUE
HPTLC : SEPERATION TECHNIQUErx_sonali
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005Patel Parth
 
Evaluation of dosage forms
Evaluation of dosage formsEvaluation of dosage forms
Evaluation of dosage formsShaik Sana
 
Microbiology &Antibiotics
Microbiology &AntibioticsMicrobiology &Antibiotics
Microbiology &AntibioticsShilpa Garg
 
Sterility test and modern microbiological methods
Sterility test and modern microbiological methodsSterility test and modern microbiological methods
Sterility test and modern microbiological methodsMohammed Fawzy
 
Bacterial Endotoxin Test
Bacterial Endotoxin TestBacterial Endotoxin Test
Bacterial Endotoxin TestPharmaguideline
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014Patel Parth
 

En vedette (14)

23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms
 
Qc lab 112070804001
Qc lab 112070804001Qc lab 112070804001
Qc lab 112070804001
 
Microbial limit test 112070804013
Microbial limit test  112070804013Microbial limit test  112070804013
Microbial limit test 112070804013
 
Bioassay 112070804012
Bioassay 112070804012Bioassay 112070804012
Bioassay 112070804012
 
HPTLC : SEPERATION TECHNIQUE
HPTLC : SEPERATION TECHNIQUEHPTLC : SEPERATION TECHNIQUE
HPTLC : SEPERATION TECHNIQUE
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005
 
Endotoxin testing
Endotoxin testing Endotoxin testing
Endotoxin testing
 
Evaluation of dosage forms
Evaluation of dosage formsEvaluation of dosage forms
Evaluation of dosage forms
 
Microbiology &Antibiotics
Microbiology &AntibioticsMicrobiology &Antibiotics
Microbiology &Antibiotics
 
FTIR
FTIRFTIR
FTIR
 
Sterility test and modern microbiological methods
Sterility test and modern microbiological methodsSterility test and modern microbiological methods
Sterility test and modern microbiological methods
 
HPTLC
HPTLCHPTLC
HPTLC
 
Bacterial Endotoxin Test
Bacterial Endotoxin TestBacterial Endotoxin Test
Bacterial Endotoxin Test
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014
 

Similaire à Eva. bio. & toxicity 112070804015

Genotoxicity_studies M pharmacy Pharmacology.pptx
Genotoxicity_studies M pharmacy Pharmacology.pptxGenotoxicity_studies M pharmacy Pharmacology.pptx
Genotoxicity_studies M pharmacy Pharmacology.pptxAyodhya Paradhe
 
Screnning of immunomodolator
Screnning of immunomodolatorScrenning of immunomodolator
Screnning of immunomodolatorssuser3f154a
 
Mutagenicity, Carcinogenicity, Genotoxicity Tests
Mutagenicity, Carcinogenicity, Genotoxicity TestsMutagenicity, Carcinogenicity, Genotoxicity Tests
Mutagenicity, Carcinogenicity, Genotoxicity Testsarchanas465570
 
Antioxidant and Antitumor Activities on Catunaregum spinosa
Antioxidant and Antitumor Activities on Catunaregum spinosaAntioxidant and Antitumor Activities on Catunaregum spinosa
Antioxidant and Antitumor Activities on Catunaregum spinosapharmaindexing
 
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...James Silverman
 
Lecture 3 standardization of animal expmts
Lecture 3 standardization of animal expmtsLecture 3 standardization of animal expmts
Lecture 3 standardization of animal expmtsBruno Mmassy
 
Ecology Practicals2
Ecology Practicals2Ecology Practicals2
Ecology Practicals2medik.cz
 
Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulatorsAanchal46
 
Terpenoids as an alternative tool for pest control
Terpenoids as an alternative tool for pest controlTerpenoids as an alternative tool for pest control
Terpenoids as an alternative tool for pest controlkareem Esmaiel
 
OECD Guidlines By Genotoxicity
OECD Guidlines By GenotoxicityOECD Guidlines By Genotoxicity
OECD Guidlines By GenotoxicityShital Magar
 
The Importance Of Animal Uses In Animals
The Importance Of Animal Uses In AnimalsThe Importance Of Animal Uses In Animals
The Importance Of Animal Uses In AnimalsJessica Lopez
 
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo RuizLack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo RuizJuan Restrepo Ruiz
 
Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1cwoodland
 
Biologic therapy for psoriasis
Biologic therapy for psoriasisBiologic therapy for psoriasis
Biologic therapy for psoriasisAhmed Amer
 

Similaire à Eva. bio. & toxicity 112070804015 (20)

Genotoxicity_studies M pharmacy Pharmacology.pptx
Genotoxicity_studies M pharmacy Pharmacology.pptxGenotoxicity_studies M pharmacy Pharmacology.pptx
Genotoxicity_studies M pharmacy Pharmacology.pptx
 
Genotoxicity studies
Genotoxicity studiesGenotoxicity studies
Genotoxicity studies
 
Screnning of immunomodolator
Screnning of immunomodolatorScrenning of immunomodolator
Screnning of immunomodolator
 
Mutagenicity, Carcinogenicity, Genotoxicity Tests
Mutagenicity, Carcinogenicity, Genotoxicity TestsMutagenicity, Carcinogenicity, Genotoxicity Tests
Mutagenicity, Carcinogenicity, Genotoxicity Tests
 
Antioxidant and Antitumor Activities on Catunaregum spinosa
Antioxidant and Antitumor Activities on Catunaregum spinosaAntioxidant and Antitumor Activities on Catunaregum spinosa
Antioxidant and Antitumor Activities on Catunaregum spinosa
 
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
 
Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animals
 
Lecture 3 standardization of animal expmts
Lecture 3 standardization of animal expmtsLecture 3 standardization of animal expmts
Lecture 3 standardization of animal expmts
 
Ecology Practicals2
Ecology Practicals2Ecology Practicals2
Ecology Practicals2
 
Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulators
 
Haseeb ahsan
Haseeb ahsanHaseeb ahsan
Haseeb ahsan
 
Terpenoids as an alternative tool for pest control
Terpenoids as an alternative tool for pest controlTerpenoids as an alternative tool for pest control
Terpenoids as an alternative tool for pest control
 
OECD Guidlines By Genotoxicity
OECD Guidlines By GenotoxicityOECD Guidlines By Genotoxicity
OECD Guidlines By Genotoxicity
 
The Importance Of Animal Uses In Animals
The Importance Of Animal Uses In AnimalsThe Importance Of Animal Uses In Animals
The Importance Of Animal Uses In Animals
 
AMES test.pptx
AMES test.pptxAMES test.pptx
AMES test.pptx
 
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo RuizLack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario Biología Molecular-Juan Restrepo Ruiz
 
NYCSEF
NYCSEFNYCSEF
NYCSEF
 
Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1
 
Phototoxicity copy
Phototoxicity   copyPhototoxicity   copy
Phototoxicity copy
 
Biologic therapy for psoriasis
Biologic therapy for psoriasisBiologic therapy for psoriasis
Biologic therapy for psoriasis
 

Plus de Patel Parth

Automated analysis by yatin sankharva copy
Automated analysis by yatin sankharva   copyAutomated analysis by yatin sankharva   copy
Automated analysis by yatin sankharva copyPatel Parth
 
Automated analysis 112070804013
Automated analysis 112070804013Automated analysis 112070804013
Automated analysis 112070804013Patel Parth
 
Anda registration in us eu
Anda registration in us  euAnda registration in us  eu
Anda registration in us euPatel Parth
 
Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Patel Parth
 
Analysis of solid oral
Analysis of solid oralAnalysis of solid oral
Analysis of solid oralPatel Parth
 
Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Patel Parth
 
Analysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarAnalysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarPatel Parth
 
Analysis of data (pratik)
Analysis of data (pratik)Analysis of data (pratik)
Analysis of data (pratik)Patel Parth
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Patel Parth
 
A seminar on applications of various analytical technique
A seminar on applications of various analytical techniqueA seminar on applications of various analytical technique
A seminar on applications of various analytical techniquePatel Parth
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysisPatel Parth
 
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotechPatel Parth
 
A.a sequence analysis 112070804002
A.a sequence analysis 112070804002A.a sequence analysis 112070804002
A.a sequence analysis 112070804002Patel Parth
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014Patel Parth
 
Pyrogen 112070804004
Pyrogen  112070804004Pyrogen  112070804004
Pyrogen 112070804004Patel Parth
 
Gcp 112070804017
Gcp 112070804017Gcp 112070804017
Gcp 112070804017Patel Parth
 
Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001Patel Parth
 

Plus de Patel Parth (20)

Automated analysis by yatin sankharva copy
Automated analysis by yatin sankharva   copyAutomated analysis by yatin sankharva   copy
Automated analysis by yatin sankharva copy
 
Automated analysis 112070804013
Automated analysis 112070804013Automated analysis 112070804013
Automated analysis 112070804013
 
Anda registration in us eu
Anda registration in us  euAnda registration in us  eu
Anda registration in us eu
 
Anda ppt
Anda pptAnda ppt
Anda ppt
 
Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009
 
Analysis of solid oral
Analysis of solid oralAnalysis of solid oral
Analysis of solid oral
 
Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010
 
Analysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarAnalysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminar
 
Analysis of data (pratik)
Analysis of data (pratik)Analysis of data (pratik)
Analysis of data (pratik)
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018
 
Agencies dhwani
Agencies dhwaniAgencies dhwani
Agencies dhwani
 
A seminar on applications of various analytical technique
A seminar on applications of various analytical techniqueA seminar on applications of various analytical technique
A seminar on applications of various analytical technique
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysis
 
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
 
A.a sequence analysis 112070804002
A.a sequence analysis 112070804002A.a sequence analysis 112070804002
A.a sequence analysis 112070804002
 
Chi square test
Chi square testChi square test
Chi square test
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014
 
Pyrogen 112070804004
Pyrogen  112070804004Pyrogen  112070804004
Pyrogen 112070804004
 
Gcp 112070804017
Gcp 112070804017Gcp 112070804017
Gcp 112070804017
 
Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001
 

Eva. bio. & toxicity 112070804015

  • 1. GUIDED BY: PREPARED BY: MR PRAVIN MESARIYA M.Pharm (Q.A) Sem-1
  • 2. EVALUATION OF ANALGESIC AGENTS:  THERMAL STIMULUS  Hot-plate test  Mice on hot plate at 55°c.  cut off time 30 sec  PHYSICAL STIMULUS  Haffner’s tail clip method  A metal artery clip was applied to the root of the mouse’s tail for 30 sec.
  • 3. Writhing test  the mice were given an intraperitoneal (i.p.) injection of 0.6% v/v acetic acid in a volume of 10ml/kg to induce the characteristic writhings.
  • 4. Carrageenan-Induced Rat Paw Edema: Animals of group I received normal saline (3 ml/kg b.w. intraperitoneal, i.p) and served as saline control. The .groups II and III received methanol extract of . Clerodendron infortunatum (250 and 500 mg/kg b.w., i.p, . respectively) and group IV received reference drug . phenylbutazone (100 mg/kg b. w., i.p)..
  • 5. EHRLICH ASCITES CARCINOMA(EAC)  weekly intraperitoneal inoculation of 106 cells per mouse.  Substances under investigation are administered either orally or intraperitoneally.  The viability of the cells are judged by the trypan blue test  viable tumour cell count is done using haemocytometer.
  • 6. is induced in Balb-C mice by subcutaneous injection of 3-methylcholanthrene(3-MC).
  • 7.  defn  The capability of producing fetal malformation.  A given teratogen may be organ specific. It may be species specific. It can be dose specific.  teratogens  halidomide Accutane  Diethylstilbestrol(DES) Alcohol  OBSERVATION PARAMETERS
  • 8.  Multigenerational studies Single generational studies Segment I:Evaluation of Fertility and Reproductive Performance Segment II: Assessment of Developmental Toxicity Segment II: Postnatal Evaluation  Tests under ICH:  Fertility Assessment Postnatal Evaluation and Pregnancy State Susceptibility Assessment of Developmental Toxicity
  • 9.  diagnosis  · colon & Rectal Cancer: Home Testing  Home Colorectal Cancer Tests  Home Fecal Occult Bleeding Tests  · Pregnancy -- Related Home Testing:   Home Pregnancy Tests
  • 10. Mutation  A change in the DNA molecule  Process which produces changes in the DNA that may be inherited.  MECHANISM  1. By the change in the structure of DNA which is responsible in inaccurate application of genome.  2. Prevent cell proliferation that fixes the DNA damage.  3. DNA repair removal of large segement of DNA.
  • 11. Chemical (different compounds) ◦ Alkylating agents ◦ Aromatic hydrocarbons (e.g. benzo(a)pyrene) ◦ Intercalating agents (e.g. fluorescent dyes) ◦ Artificial derivatives of DNA bases  Physical (ionizing radiation, UV-radiation)  Biological (viruses, transposable elements)
  • 12. Induction of in vitro mammalian cells resistant to certain chemical compound ◦ (e.g. 8-azaguanine, 6-thioguanin, ouabain)  SOS/umu test – measurement of DNA repair in bacteria ◦ The bacteria is transformed by plasmide with mutator (repair) genes umuC and umuD fused with the gene for galactosidase. If the DNA is damaged by mutagen both umu mutator genes and gal gene are transcribed and galactosidase turns a specific substrate into a color product. 
  • 13. Test system – auxotrophic strain of Salmonella typhimurium – survives only in medium with histidine (dies in normal medium without histidine)  After treatment with mutagen some auxotrophic cells are turned into normal ones that synthesize histidine and survive in a normal medium.  These cells are called revertants (due to reverse mutation).
  • 14. Mutagen His– Reverse mutation His+ bacteria bacteria Medium Dies in a Normal containing normal medium histidine medium
  • 15. 0 Negative control SPONTANEOUS REVERTANTS A dish with GENOTOXICITY a CONFIRMED compound to be tested Positive IS USED FOR CONTROL OF control THE TEST
  • 16. Number of revertant colonies Dose of 1-nitropyrene (micrograms per dish)  The graph describes results of the Ames test of various 1-nitropyrene doses.  Describe the relationship between the dose and number of revertant colonies. Is it possible to confirm the mutagenic activity?  Why we test the compound in various concentrations?
  • 17. ijppsjournal.com/Vol1Issue2/171.pdf  healthy-synergies.com/Documents/2-2-33- 36.pdf  GHOSH M.N. Fundamentals of experimentaL pharmacology, Fourth Edition 2008. Page no.162-173.